BOLTON SECURITIES CORPORATION’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$107K	Sell	2,678 -25	-0.9%	-$894	﹤0.01%	1107
2026 Q2	$91.6K	Buy	2,703 +828	+44%	+$27.6K	﹤0.01%	1142
2026 Q1	$56.5K	Buy	+1,875	New	+$60.3K	﹤0.01%	1201
2025 Q3	$37.9K	Buy	+1,875	New	+$32.9K	﹤0.01%	1212
2025 Q1	$336K	Buy	+21,875	New	+$391K	0.02%	575

Other funds holding TEVA

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.8B AUM 42.86% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $59.1B AUM 41.96% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $20.7B AUM 58.31% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $16.3B AUM 54.64% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $21.3B AUM 44.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $5.74B AUM 42.24% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's TEVA Position: Q3 2026 in Review

BOLTON SECURITIES CORPORATION reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 0.92% in Q3 2026, selling an estimated $894 and leaving 2,678 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #1107.

BOLTON SECURITIES CORPORATION first reported a position in TEVA in Q1 2025 and has held it in 5 quarters since. The position peaked at $336K in Q1 2025. 379 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

BOLTON SECURITIES CORPORATION held 2,678 shares of Teva Pharmaceutical Industries Limited worth $107K as of Q3 2026.
BOLTON SECURITIES CORPORATION sold 25 Teva Pharmaceutical Industries Limited shares in Q3 2026, an estimated $894.
Teva Pharmaceutical Industries Limited made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q3 2026, its #1107 holding.
BOLTON SECURITIES CORPORATION first reported a position in Teva Pharmaceutical Industries Limited in Q1 2025 and has held it in 5 quarters since.
BOLTON SECURITIES CORPORATION's Teva Pharmaceutical Industries Limited position peaked at $336K in Q1 2025.
379 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2026, filed 12 Nov 2026.